Capital World Investors Grifols Sa Transaction History

Capital World Investors

$592 Billion
Q1 2025

A detailed history of Capital World Investors transactions in Grifols Sa stock. As of the latest transaction made, Capital World Investors holds 21,522,236 shares of GRFS stock, worth $172 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

21,522,236

Previous 21,134,230 1.84%

Holding current value

$172 Million

Previous $157 Million 2.68%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$6.62 - $8.71 $2.57 Million - $3.38 Million	388,006 Added 1.84%	21,522,236 $153 Million
Q4 2024 Feb 13, 2025	BUY	$6.99 - $9.55 $1.08 Million - $1.47 Million	154,358 Added 0.74%	21,134,230 $157 Million
Q3 2024 Nov 13, 2024	BUY	$6.28 - $9.38 $566,669 - $846,394	90,234 Added 0.43%	20,979,872 $186 Million
Q2 2024 Aug 13, 2024	BUY	$6.27 - $7.7 $880,389 - $1.08 Million	140,413 Added 0.68%	20,889,638 $132 Million
Q1 2024 May 14, 2024	BUY	$5.47 - $11.38 $5.26 Million - $10.9 Million	961,700 Added 4.86%	20,749,225 $139 Million
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $1.22 Million - $1.83 Million	158,474 Added 0.81%	19,787,525 $229 Million
Q3 2023 Nov 13, 2023	BUY	$8.91 - $10.91 $1.01 Million - $1.24 Million	113,295 Added 0.58%	19,629,051 $179 Million
Q2 2023 Aug 11, 2023	BUY	$7.14 - $9.29 $738,597 - $961,004	103,445 Added 0.53%	19,515,756 $179 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $87,819 - $141,172	13,206 Added 0.07%	19,412,311 $143 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $9.12 Million - $13.1 Million	1,530,078 Added 8.56%	19,399,105 $165 Million
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $4.4 Million - $10.6 Million	739,432 Added 4.32%	17,869,027 $110 Million
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $451,008 - $565,037	-42,548 Reduced 0.25%	17,129,595 $203 Million
Q1 2022 May 16, 2022	BUY	$10.37 - $12.73 $23.5 Million - $28.8 Million	2,265,005 Added 15.19%	17,172,143 $201 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $19.7 Million - $29.5 Million	1,932,123 Added 14.89%	14,907,138 $167 Million
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $6.81 Million - $8.38 Million	-484,228 Reduced 3.6%	12,975,015 $190 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $1.47 Million - $1.68 Million	88,665 Added 0.66%	13,459,243 $234 Million
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $26.9 Million - $35.2 Million	1,777,429 Added 15.33%	13,370,578 $231 Million
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $15.5 Million - $18.1 Million	918,025 Added 8.6%	11,593,149 $214 Million
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $155 Million - $203 Million	10,058,724 Added 1631.85%	10,675,124 $185 Million
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $12.4 Million - $13.5 Million	616,400	616,400 $13.5 Million

Others Institutions Holding GRFS

# of Institutions

166

Shares Held

153M

Call Options Held

76.5K

Put Options Held

106K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.43B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Grifols Sa Transaction History